Table 1 Demographic and clinical characteristics of PD patients and controls

From: Diffusion–tensor MRI study of the relationship between glymphatic system asymmetry and onset lateralization in Parkinson’s disease

 

PD

 

HCs

P value

 
 

LPD

RPD

 

LPD vs RPD

PD vs HCs

n

36

27

49

  

Clinical variables

 Age (y)

62.64 ± 6.40

61.41 ± 7.35

63.39 ± 4.97

0.481

0.227

 Gender (Male/Female)

21/15

15/12

30/19

0.825

0.663

 Education duration (y)

10.42 ± 3.83

10.19 ± 4.10

11.40 ± 2.98

0.819

0.109

 Disease duration (y)

5.65 ± 3.33

6.05 ± 3.75

NA

0.662

NA

 H &Y stage

2.11 ± 0.75

2.11 ± 0.67

NA

0.986

NA

 LEDD (mg/d)

725.00 (431.25, 981.25)

587.50 (328.13, 692.63)

NA

0.074

NA

Motor symptom

 UPDRS-III score

30.58 ± 16.31

30.89 ± 10.79

NA

0.933

NA

 Bradykinesia score

15.13 ± 7.96

16.44 ± 6.44

NA

0.573

NA

 Rigidity score

7.83 ± 3.81

8.28 ± 4.21

NA

0.721

NA

 PIGD score

5.31 ± 4.38

5.33 ± 4.02

NA

0.980

NA

 TD score

5.50 (2.00, 10.00)

4.50 (2.00, 9.00)

NA

0.823

NA

Motor performance

 TUG (s)

14.14 ± 4.63

11.70 ± 5.36

NA

0.066

NA

 Tinetti Gait score

9.20 ± 2.82

8.93 ± 3.29

NA

0.725

NA

 Tinetti Balance score

13.51 ± 3.74

13.78 ± 2.69

NA

0.758

NA

 FOG score

1.00 (0.00, 10.00)

1.00 (0.00, 8.00)

NA

0.958

NA

Mental and cognitive impairment

 MMSE score

27.09 ± 2.30

28.07 ± 1.69

28.92 ± 1.06

0.067

<0.001*

 FAB score

16.09 ± 1.84

15.85 ± 2.32

17.00 ± 1.07

0.659

0.003*

 HARS score

11.71 ± 7.03

11.63 ± 7.66

3.35 ± 3.58

0.964

<0.001*

 HDRS score

13.35 ± 10.81

13.32 ± 9.01

1.73 ± 2.27

0.992

<0.001*

 AS score

14.14 ± 7.01

11.72 ± 4.91

NA

0.225

NA

Sleep disorders

 ESS score

8.00 (3.00, 12.00)

4.00 (3.00, 8.00)

NA

0.131

NA

 PDSS score

122.81 ± 23.84

122.96 ± 23.46

NA

0.981

NA

 RBDSQ score

4.92 ± 3.65

4.00 ± 3.17

NA

0.302

NA

  1. Continuous variables are presented as mean ± standard deviation for parametric data and median (interquartile range) for nonparametric data.
  2. PD Parkinson’s disease, LPD Left-onset Parkinson’s disease, RPD right-onset Parkinson’s disease, HCs healthy controls, y years, H&Y Hoehn and Yahr, LEDD levodopa equivalent daily dose, UPDRS unified Parkinson’s disease rating scale, PIGD postural instability/gait difficulty, TD tremor dominant, TUG timed up and go, FOG freezing of gait, MMSE mini-mental state examination, FAB frontal assessment battery, HARS Hamilton anxiety rating scale, HDRS Hamilton depression rating scale, AS apathy scale, ESS excessive daytime sleepiness scale, PDSS Parkinson’s disease sleep scale, RBDSQ rapid sleep behavior disorder questionnaire, NA not applicable.